Low level of fibrillarin, a ribosome biogenesis factor, is a new independent marker of poor outcome in breast cancer

HIGHLIGHTS

• who: Flora Nguyen Van Long from the Laennec, , Lyon, France have published the article: Low level of Fibrillarin, a ribosome biogenesis factor, is a new independent marker of poor outcome in breast cancer, in the Journal: (JOURNAL)
• what: The authors determine whether FBL is a marker of patient outcome at early stages of breast cancer that might reflect ribosome biogenesis activity. Since few events occurred in the IGR-2 series, the authors focused on the association of FBL mRNA levels with distant disease-free survival (dDFS) and the authors used the tercile as cut-off . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.